Medication Fact Sheets
|
April 23, 2025

Vancomycin Hydrochloride Side Effects: A Comprehensive Guide

Medically Reviewed by
Updated On
April 29, 2025

Vancomycin is a powerful ally in the fight against serious bacterial infections. Often used when other antibiotics fail, it is commonly prescribed for resistant organisms like MRSA (methicillin-resistant Staphylococcus aureus). But like any potent medication, vancomycin can cause side effects—some mild, others more serious.

This guide thoroughly examines vancomycin’s most common and serious side effects. It also discusses who may be at higher risk and how side effects can be monitored and managed effectively.

[signup]

Overview of Vancomycin Hydrochloride

Before exploring the side effects, it’s important to understand what vancomycin is and how it works in the body.

What Is Vancomycin and How Does It Work?

Vancomycin is a tricyclic glycopeptide antibiotic that kills bacteria by interfering with their cell wall formation. When given orally, it is especially effective against Gram-positive bacteria, including MRSA and Clostridioides difficile (C. diff).

Common Uses and Administration Methods

Vancomycin has several clinical uses.  

FDA-Approved Indications:

The following off-label uses are supported by clinical experience but are not FDA-approved. Use should be based on individual clinical judgment:

It is often given intravenously, but the oral form is used specifically for gastrointestinal infections like C. diff, as it stays in the gut and is not absorbed into the bloodstream.

Importance of Proper Dosing and Monitoring

Monitoring is essential because vancomycin has a narrow therapeutic window, meaning the effective dose is close to the toxic dose. Blood levels are often checked to ensure the drug remains within a safe and effective range. Incorrect dosing can increase the risk of serious side effects, particularly kidney and hearing damage.

Common Side Effects of Vancomycin

Like many antibiotics, vancomycin may cause mild side effects, especially at the beginning of treatment or with higher doses.

Gastrointestinal Reactions

  • Nausea and Vomiting: These are among the most commonly reported symptoms, particularly when vancomycin is taken orally.
  • Abdominal Pain and Diarrhea: Gastrointestinal upset may occur with oral or IV administration.

Skin Reactions

  • Red Man Syndrome (Vancomycin infusion reaction): This is not a true allergic reaction but rather a histamine release that can cause flushing, redness, itching, and sometimes low blood pressure. It usually occurs during or shortly after IV infusion and can be reduced by slowing the infusion rate and giving antihistamines.
  • Rash and Itching: Mild skin rashes and itching may occur, particularly on the upper body, face, or neck.

Metabolic Disturbances 

  • Hypokalemia (Low Potassium Levels): This may occur, especially with prolonged therapy, and can cause fatigue, muscle cramps, or abnormal heart rhythms. Electrolyte levels should be monitored during treatment.

Serious Side Effects and Complications

While uncommon, serious adverse effects can occur and may require dose adjustment, drug discontinuation, or medical intervention.

Nephrotoxicity (Kidney Damage)

Vancomycin may impair kidney function, especially at high doses or when combined with other nephrotoxic drugs. Signs of kidney injury may include reduced urine output, elevated creatinine levels, or swelling in the legs and ankles. Close monitoring of renal function is essential in hospitalized or high-risk patients.

Ototoxicity (Hearing Loss)

Vancomycin has been associated with damage to the inner ear, particularly when used in high doses or with other ototoxic drugs such as aminoglycosides. Symptoms may include hearing loss, ringing in the ears (tinnitus), or balance problems.

Blood Disorders

In rare cases, vancomycin may affect blood cell counts, potentially causing neutropenia (low white blood cells), thrombocytopenia (low platelets), or eosinophilia (elevated eosinophils). Routine blood tests can help detect these changes early.

Antibiotic Fever

Antibiotic fever is a type of hypersensitivity reaction that occurs without an infection-related cause. It typically presents as a persistent or recurrent fever that begins a few days after starting the medication and resolves once the drug is stopped.

Allergic Reactions

True allergic reactions to vancomycin are rare but possible. Symptoms may include hives, swelling, breathing difficulty, or anaphylaxis. If any signs of a severe allergic response occur, immediate medical attention is required.

Risk Factors for Vancomycin Side Effects

Some individuals may be more susceptible to side effects due to age, health status, or interactions with other medications. Identifying these risk factors can help personalize vancomycin therapy and minimize complications.

Age-Related Risks

  • Older Adults: Increased sensitivity to vancomycin’s toxic effects on the kidneys and ears.
  • Infants and Young Children: Dosing must be carefully adjusted due to immature organ function and differences in drug metabolism.

Pre-existing Medical Conditions

  • Kidney Disease: Individuals with reduced kidney function are at higher risk for nephrotoxicity.
  • Hearing Impairment: Existing hearing loss may worsen with vancomycin use.

Drug Interactions

Combining vancomycin with other nephrotoxic or ototoxic medications (such as aminoglycosides, loop diuretics, or NSAIDs) increases the likelihood of adverse effects. Medicines that may interact with vancomycin include:

  • Aminoglycosides (e.g., gentamicin, tobramycin): May increase the risk of kidney damage or hearing loss
  • Diuretics (furosemide/Lasix): Can raise the risk of kidney problems
  • NSAIDs (e.g., ibuprofen, naproxen): May affect kidney function when combined with vancomycin
  • Some Anesthetics: May increase the chance of low blood pressure or other side effects during surgery
  • Other antibiotics (e.g., amphotericin B): May increase the risk of side effects, especially kidney-related

Before starting vancomycin, always tell your healthcare provider about all the medications, supplements, and vitamins you're taking.

Monitoring and Managing Vancomycin Side Effects

Monitoring vancomycin therapy is essential to ensure effectiveness while reducing the risk of complications. 

Therapeutic Drug Monitoring (TDM)

Vancomycin blood levels are regularly checked, especially in hospitalized patients. Target trough levels depend on the type and severity of infection but typically range from 10–20 mcg/mL.

Strategies to Minimize Adverse Reactions

  • Slow IV infusion rates to prevent Red Man Syndrome
  • Hydration to support kidney function
  • Regular monitoring of renal function, hearing, and electrolyte levels
  • Avoiding concurrent use of interacting drugs when possible

When to Seek Medical Attention

Patients are advised to contact their healthcare provider promptly if they experience:

  • Unusual rash, itching, or swelling
  • Decreased urination or swelling of the legs
  • Ringing in the ears or hearing loss
  • Shortness of breath or chest tightness

Special Considerations

Due to physiological differences or limited safety data, certain populations require special attention when using vancomycin.

  • Vancomycin Use in Pregnancy and Breastfeeding - Vancomycin crosses the placenta and is found in breast milk, but available data suggest it may be safe when the benefits outweigh the risks. Close monitoring is advised during pregnancy, and lactating individuals should consult their healthcare provider.
  • Pediatric Patients and Vancomycin - Dosing in children must be weight-based and adjusted for age. Young children may clear the drug more rapidly, requiring more frequent dosing and careful monitoring.
  • Elderly Patients and Increased Sensitivity - Older adults may be more sensitive to vancomycin’s nephrotoxic and ototoxic effects. Dose adjustments and enhanced monitoring are often necessary in this age group.

Frequently Asked Questions (FAQs)

Q: Can vancomycin side effects be long-lasting?
Most side effects of vancomycin are temporary and resolve after treatment ends. However, in rare cases, certain effects—such as hearing loss (ototoxicity) or kidney damage (nephrotoxicity)—may be prolonged or irreversible, particularly with high doses or long-term use. A healthcare provider should closely monitor patients during treatment.

Q: How common is antibiotic resistance with vancomycin?
Vancomycin-resistant bacteria, such as vancomycin-resistant enterococci (VRE), are uncommon but have become a serious concern in healthcare settings. Resistance typically develops due to overuse or misuse of antibiotics. Appropriate use and infection control practices help reduce the risk of resistance.

Q: Are there alternatives to vancomycin with fewer side effects?
Aternatives may be available depending on the type of infection and the bacteria involved. Options may include linezolid, daptomycin, or ceftaroline, among others. The infection type, patient history, and lab testing should guide the choice of antibiotic. A healthcare provider can determine the most appropriate treatment.

Q: What should I do if I experience severe side effects from vancomycin?
Contact a healthcare provider immediately if you experience rash, difficulty breathing, dizziness, hearing changes, or reduced urine output. Severe side effects may require discontinuation or adjustment of the medication and additional medical evaluation.

Q: Can lifestyle changes help reduce the risk of vancomycin side effects?
While lifestyle changes cannot directly prevent vancomycin side effects, maintaining adequate hydration, avoiding alcohol or other nephrotoxic drugs, and reporting symptoms early may help reduce risks. It’s important to follow the healthcare provider’s instructions carefully throughout treatment.

[signup]

Key Takeaways

  • Vancomycin is a powerful antibiotic commonly used to treat serious bacterial infections, especially those resistant to other antibiotics.
  • Most side effects are temporary, but in rare cases, vancomycin can cause long-lasting complications such as hearing loss or kidney damage.
  • Monitoring during treatment is essential, especially for patients receiving high doses or long-term therapy.
  • Vancomycin resistance, though uncommon, is a growing concern in healthcare settings and can be minimized through appropriate use.
  • Alternatives to vancomycin exist, and the best option depends on the specific infection, bacterial strain, and patient health history.
  • Patients should report any severe side effects immediately and follow healthcare provider instructions carefully to minimize risks.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Alharbi, H. H., Al-Qurainees, G. I., & Al-Hebshi, A. (2022). Vancomycin-Induced Fever and Neutropenia in an Immunocompetent Patient With Complicated Community-Acquired Pneumonia. Cureus. https://doi.org/10.7759/cureus.26630

Black, E., Lau, T. T., & Ensom, M. H. (2011). Vancomycin-Induced Neutropenia: Is it Dose- or Duration-Related? Annals of Pharmacotherapy, 45(5), 629–638. https://doi.org/10.1345/aph.1p583

Bryant, A. (2024, August 16). Endocarditis: Understanding causes, symptoms, and treatment options. Rupa Health. https://www.rupahealth.com/post/endocarditis-understanding-causes-symptoms-and-treatment-options

Filippone, E., Kraft, W., & Farber, J. (2017). The Nephrotoxicity of Vancomycin. Clinical Pharmacology & Therapeutics, 102(3), 459–469. https://doi.org/10.1002/cpt.726

Fishbein, S. R. S., Hink, T., Reske, K. A., Cass, C., Struttmann, E., Iqbal, Z. H., Seiler, S., Kwon, J. H., Burnham, C.-A. D., Dantas, G., & Dubberke, E. R. (2021). Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients. MSphere, 6(1), e00936-20. https://doi.org/10.1128/mSphere.00936-20

Kampmeier, S., Kossow, A., Clausen, L. M., Knaack, D., Ertmer, C., Gottschalk, A., Freise, H., & Mellmann, A. (2018). Hospital acquired vancomycin resistant enterococci in surgical intensive care patients – a prospective longitudinal study. Antimicrobial Resistance & Infection Control, 7(1). https://doi.org/10.1186/s13756-018-0394-1

Martel, T. J., Jamil, R. T., & King, K. C. (2020). Red Man Syndrome. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK482506/

Nanovskaya, T., Patrikeeva, S., Zhan, Y., Fokina, V., Hankins, G. D. V., & Ahmed, M. S. (2012). Transplacental transfer of vancomycin and telavancin. American Journal of Obstetrics and Gynecology, 207(4), 331.e1–331.e6. https://doi.org/10.1016/j.ajog.2012.06.064

NHS Choices. (2021, June 10). Staph Infection. NHS. https://www.nhs.uk/conditions/staphylococcal-infections/

Patel, S., Preuss, C. V., & Bernice, F. (2024a, October 29). Vancomycin. National Library of Medicine; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK459263/

Patel, S., Preuss, C. V., & Bernice, F. (2024b, October 29). Vancomycin. National Library of Medicine; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK459263/

Salen, P., & Stankewicz, H. A. (2020). Pseudomembranous Colitis. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK470319/

Smolle, M. (2024). Trial of Vancomycin and Cefazolin as Surgical Prophylaxis. The New England Journal of Medicine, 390(5), 480–482. https://doi.org/10.1056/nejmc2313673

Stanford, J. (2024, June 20). NSAIDs Fact Sheet: Uses, Benefits, Risks, and More. Rupa Health. https://www.rupahealth.com/post/nsaids-fact-sheet

Taubenslag, K. J., Cherney, E. F., Patel, S. N., Law, J. C., Daniels, A. B., & Kim, S. J. (2023). Intravitreal triple therapy with vancomycin, ceftazidime, and moxifloxacin for bacterial endophthalmitis: A Twelve-year experience. Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie, 261(10), 2813–2819. https://doi.org/10.1007/s00417-023-06112-2

Timpe, E. M. (2005). Nephrotoxicity with Combination Vancomycin-Aminoglycoside Therapy. The Journal of Pediatric Pharmacology and Therapeutics, 10(3), 174–182. https://doi.org/10.5863/1551-6776-10.3.174

Yablon, S. A., Krotenberg, R., & Fruhmann, K. (1992). DIARRHEA IN HOSPITALIZED PATIENTS. American Journal of Physical Medicine & Rehabilitation, 71(2), 102–107. https://doi.org/10.1097/00002060-199204000-00008

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Medication Fact Sheets
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.

Hey practitioners! :wave: Join Dr. Cheryl Burdette, ND for a free webinar, "Understanding Immune Balance in Autoimmunity," on Thursday, May 7th, at 09:00AM PT / 12:00PM EST.

In this class, you'll gain insight into how gut health and immune balance may be connected, the role of key markers like Zonulin and oxidative stress indicators, and strategies to help support gut barrier integrity and immune resilience.

Register now to secure your spot!